This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Marc H. Lebel, MD; M. Jean Hoyt, RN; David C. Waagner, MD; Nancy K. Rollins, MD; Terese Finitzo, PhD; George H. McCracken, Jr, MD

Am J Dis Child. 1989;143(3):301-306.

Abstract
• We conducted a third placebo-controlled, double-blind study of dexamethasone as adjunctive therapy for bacterial meningitis. Thirty-one patients received cefuroxime sodium (300 mg/kg per day in 3 doses) and dexamethasone phosphate (0.6 mg/kg per day in 4 doses for 4 days), and 29 received cefuroxime and placebo. The groups were comparable at the beginning of therapy. Magnetic resonance imaging performed between days 2 and 5 of therapy was used to assess brain water content indirectly. There were no differences between the 2 treatment groups with respect to the T₁- or T₂-weighted images. Fifty-two patients (88%) had normal magnetic resonance images; 5 patients had parietal or bifrontal extra-axial fluid collections, and 2 children had areas of abnormal signal intensity in the brain on T₂-weighted images. Abnormal findings on magnetic resonance imaging did not alter clinical management, and there was no correlation between the results of magnetic resonance imaging and the outcome of meningitis. The number of patients in this study was too small to determine any statistically significant differences in rates of hearing impairment; however, the cerebrospinal fluid findings and clinical outcome in dexamethasone-treated patients further support the previously reported beneficial effect of corticosteroid treatment in patients with bacterial meningitis.

(AJDC. 1989;143:301-306)

Author Affiliations
From the Departments of Pediatrics (Drs Lebel, Waagner, and McCracken and Ms Hoyt) and Radiology (Dr Rollins), The University of Texas Southwestern Medical Center at Dallas, Southwestern Medical School; and the Neuroscience Research Center, Dallas (Dr Finitzo). Dr Lebel is currently with the Departments of Pediatrics and Microbiology, University of Montreal, Canada.

Footnotes
Accepted for publication January 11, 1989.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of Corticosteroids in Treating Infectious Diseases
McGee and Hirschmann
Arch Intern Med 2008;168:1034-1046.
ABSTRACT | FULL TEXT  

Acute-Phase Neurologic Complications of Haemophilus Influenzae Type b Meningitis: Association With Developmental Problems at School Age
Taylor et al.
J Child Neurol 1998;13:113-119.
ABSTRACT  

Bacterial Meningitis: Recent Advances in Pathophysiology and Treatment
Tunkel et al.
ANN INTERN MED 1990;112:610-623.
ABSTRACT